Literature DB >> 26654413

Economic Burden of Prescription Opioid Misuse and Abuse: A Systematic Review.

Gary M Oderda, Joanita Lake, Katja Rüdell, Carl L Roland, Elizabeth T Masters.   

Abstract

A 2009 systematic review found that the total cost of prescription opioid abuse in 2001 in the United States was approximately $8.6 billion and medical expenses were estimated to be $15,884 for opioid abusers and $1,830 for nonabusers. A search was conducted for English publications on the cost of prescription opioid abuse and misuse from 2009 to 2014. The initial literature search identified 5,412 citations. Title and abstract review selected 59 for further review. The final review process resulted in 16 publications for inclusion that examined cost from the payer perspective. Mean costs to the payer for abusers were $23,000-$25,000 per year and excess costs approximately $15,000 per patient. Three papers were identified that presented societal costs, including direct and indirect costs such as criminal justice costs and costs associated with lost productivity. The strongest evidence suggests that societal cost is in excess of $50 billion per year in the United States. Prescription opioid abuse and misuse is a common and important problem throughout the world that has significant associated societal costs and excess medical costs.

Entities:  

Keywords:  abuse; cost; dependence; opioids

Mesh:

Year:  2015        PMID: 26654413     DOI: 10.3109/15360288.2015.1101641

Source DB:  PubMed          Journal:  J Pain Palliat Care Pharmacother        ISSN: 1536-0288


  24 in total

1.  Opioid Use is Associated with Higher Severity-Adjusted Episode Costs in Patients with Conservatively Managed Degenerative Joint Disease of the Back and Neck.

Authors:  Brent A Metfessel; Michelle D Mentel; Amy Phanel; Mary Ann Dimartino; Mureen Allen; Samuel Ho
Journal:  Pharmacoeconomics       Date:  2019-03       Impact factor: 4.981

2.  Prescription Drug Misuse: Sources of Controlled Medications in Adolescents.

Authors:  Ty S Schepis; Timothy E Wilens; Sean Esteban McCabe
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  2018-10-30       Impact factor: 8.829

3.  Multimodal Analgesia in Outpatient Head and Neck Surgery: A Feasibility and Safety Study.

Authors:  Justin Oltman; Oleg Militsakh; Mark D'Agostino; Brittany Kauffman; Robert Lindau; Andrew Coughlin; William Lydiatt; Daniel Lydiatt; Russell Smith; Aru Panwar
Journal:  JAMA Otolaryngol Head Neck Surg       Date:  2017-12-01       Impact factor: 6.223

4.  Association between trends in county-level opioid prescribing and reported rates of gonorrhea cases in the United States.

Authors:  Winston E Abara; Jaeyoung Hong; Tandin Dorji; Michele K Bohm; Emily J Weston; Kyle T Bernstein; Robert D Kirkcaldy
Journal:  Ann Epidemiol       Date:  2019-07-04       Impact factor: 3.797

Review 5.  Back and neck pain: in support of routine delivery of non-pharmacologic treatments as a way to improve individual and population health.

Authors:  Steven Z George; Trevor A Lentz; Christine M Goertz
Journal:  Transl Res       Date:  2021-04-24       Impact factor: 7.012

6.  Does trauma exposure predict prescription drug problems beyond the contribution of post-traumatic stress disorder and depression? An analysis of the Mind Your Heart cohort study.

Authors:  Raj K Kalapatapu; Tatiana P Dannenbaum; John D Harbison; Beth E Cohen
Journal:  J Addict Dis       Date:  2017-04-07

7.  Age of initiation, psychopathology, and other substance use are associated with time to use disorder diagnosis in persons using opioids nonmedically.

Authors:  Ty S Schepis; Jahn K Hakes
Journal:  Subst Abus       Date:  2017-07-19       Impact factor: 3.716

8.  Increased health care costs associated with new persistent opioid use after major surgery in opioid-naive patients.

Authors:  Chad M Brummett; Jackie Evans-Shields; Christina England; Amanda M Kong; Carolyn R Lew; Caroline Henriques; Nicole M Zimmerman; Eric C Sun
Journal:  J Manag Care Spec Pharm       Date:  2021-02-24

9.  Do Injured Workers Receive Opioid Prescriptions Outside the Workers' Compensation System?: The Case of Private Group Health Insurances.

Authors:  Abay Asfaw; Brian Quay; Chia-Chia Chang
Journal:  J Occup Environ Med       Date:  2020-09       Impact factor: 2.162

10.  In vitro pharmacology of fentanyl analogs at the human mu opioid receptor and their spectroscopic analysis.

Authors:  Sherif H Hassanien; Jonathon R Bassman; Carmelita M Perrien Naccarato; Jack J Twarozynski; John R Traynor; Donna M Iula; Jessica P Anand
Journal:  Drug Test Anal       Date:  2020-06-11       Impact factor: 3.345

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.